- Home
- KIM vs FMS Comparison
KIM vs FMS Comparison
Compare KIM & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIM
- FMS
- Stock Information
- Founded
- KIM 1958
- FMS 1996
- Country
- KIM United States
- FMS Germany
- Employees
- KIM N/A
- FMS N/A
- Industry
- KIM Real Estate Investment Trusts
- FMS Misc Health and Biotechnology Services
- Sector
- KIM Real Estate
- FMS Health Care
- Exchange
- KIM Nasdaq
- FMS Nasdaq
- Market Cap
- KIM 16.9B
- FMS 14.1B
- IPO Year
- KIM 1991
- FMS 1996
- Fundamental
- Price
- KIM $23.28
- FMS $23.02
- Analyst Decision
- KIM Buy
- FMS Hold
- Analyst Count
- KIM 16
- FMS 1
- Target Price
- KIM $24.53
- FMS $23.00
- AVG Volume (30 Days)
- KIM 3.7M
- FMS 215.5K
- Earning Date
- KIM 02-06-2025
- FMS 02-18-2025
- Dividend Yield
- KIM 4.23%
- FMS 2.73%
- EPS Growth
- KIM N/A
- FMS 46.47
- EPS
- KIM 0.53
- FMS 2.50
- Revenue
- KIM $1,963,220,000.00
- FMS $21,457,738,113.00
- Revenue This Year
- KIM N/A
- FMS $0.24
- Revenue Next Year
- KIM $3.40
- FMS $3.41
- P/E Ratio
- KIM $44.68
- FMS $18.85
- Revenue Growth
- KIM 10.81
- FMS N/A
- 52 Week Low
- KIM $17.57
- FMS $17.93
- 52 Week High
- KIM $25.83
- FMS $24.31
- Technical
- Relative Strength Index (RSI)
- KIM 27.53
- FMS 52.85
- Support Level
- KIM $24.34
- FMS $23.58
- Resistance Level
- KIM $25.06
- FMS $24.07
- Average True Range (ATR)
- KIM 0.42
- FMS 0.31
- MACD
- KIM -0.21
- FMS -0.09
- Stochastic Oscillator
- KIM 0.39
- FMS 47.98
About KIM Kimco Realty Corporation (HC)
One of the oldest real estate investment trusts in the United States, Kimco Realty owns interests in 569 shopping centers throughout major markets in the US, representing roughly 87 million square feet.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.